Literature DB >> 7544011

Interleukin 4 signals through two related pathways.

A Pernis1, B Witthuhn, A D Keegan, K Nelms, E Garfein, J N Ihle, W E Paul, J H Pierce, P Rothman.   

Abstract

The interleukin 4 (IL-4) signaling pathway involves activation, by tyrosine phosphorylation, of two distinct substrates, a signal-transducing factor (STF-IL4) and the IL-4-induced phosphotyrosine substrate (4PS). It is not known whether the IL-4-mediated activation of these substrates occurs via related or distinct signaling pathways. We report that 32D cells, an IL-3-dependent myeloid progenitor cell line in which no phosphorylated 4PS is found, activate high levels of STF-IL4 in response to IL-4. Consistent with the known requirement for 4PS or insulin receptor substrate 1 (IRS-1) in IL-4-mediated mitogenesis, activation of STF-IL4 in 32D cells is not sufficient for IL-4-inducible c-myc expression. In addition, we have examined the ability of 32D cells transfected with different truncation mutants of the human IL-4 receptor to activate Jak-3 kinase and STF-IL4 in response to human IL-4. As in the case of 4PS/IRS-1, we have found that activation of both Jak-3 and STF-IL4 requires the presence of the IL-4 receptor region comprising aa 437-557. The finding that the same region of the IL-4 receptor is required for the induction of both 4PS/IRS-1 and STF-IL4 suggests that the IL-4-stimulated activation of these two substrates might involve common factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544011      PMCID: PMC41268          DOI: 10.1073/pnas.92.17.7971

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.

Authors:  M J Klemsz; L B Justement; E Palmer; J C Cambier
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

2.  Gamma chain-associated cytokine receptors signal through distinct transducing factors.

Authors:  A Pernis; S Gupta; J Yopp; E Garfein; H Kashleva; C Schindler; P Rothman
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

Review 3.  The IL-2 receptor complex: its structure, function, and target genes.

Authors:  Y Minami; T Kono; T Miyazaki; T Taniguchi
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 4.  The hematopoietin receptor superfamily.

Authors:  D Cosman
Journal:  Cytokine       Date:  1993-03       Impact factor: 3.861

5.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.

Authors:  L M Wang; A D Keegan; W Li; G E Lienhard; S Pacini; J S Gutkind; M G Myers; X J Sun; M F White; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4.

Authors:  H Kotanides; N C Reich
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

7.  Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element.

Authors:  I Köhler; E P Rieber
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

8.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.

Authors:  M Kondo; T Takeshita; N Ishii; M Nakamura; S Watanabe; K Arai; K Sugamura
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

9.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

10.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.

Authors:  L M Wang; M G Myers; X J Sun; S A Aaronson; M White; J H Pierce
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

View more
  19 in total

Review 1.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

2.  Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways.

Authors:  Mei-Lun Wang; Sue A Keilbaugh; Tanesha Cash-Mason; Xi C He; Linheng Li; Gary D Wu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-02       Impact factor: 4.052

3.  Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

Authors:  R Brinckmann; M S Topp; I Zalán; D Heydeck; P Ludwig; H Kühn; W E Berdel; J R Habenicht
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.

Authors:  R L Palmer-Crocker; C C Hughes; J S Pober
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Focal adhesion kinase (FAK) and mechanical stimulation negatively regulate the transition of airway smooth muscle tissues to a synthetic phenotype.

Authors:  Yidi Wu; Youliang Huang; Susan J Gunst
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-09       Impact factor: 5.464

6.  Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.

Authors:  L Soon; L Flechner; J S Gutkind; L H Wang; R Baserga; J H Pierce; W Li
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

7.  Design of conditionally active STATs: insights into STAT activation and gene regulatory function.

Authors:  L H Milocco; J A Haslam; J Rosen; H M Seidel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6.

Authors:  B K Patel; J H Pierce; W J LaRochelle
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

9.  IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma.

Authors:  Tohru Hosoyama; Mohammed Imran Aslam; Jinu Abraham; Suresh I Prajapati; Koichi Nishijo; Joel E Michalek; Lee Ann Zarzabal; Laura D Nelon; Denis C Guttridge; Brian P Rubin; Charles Keller
Journal:  Clin Cancer Res       Date:  2011-05-01       Impact factor: 12.531

10.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

Authors:  Jennifer L Gooch; Barbara Christy; Douglas Yee
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.